Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-01

AUTHORS

T Osada, D Hsu, S Hammond, A Hobeika, G Devi, T M Clay, H K Lyerly, M A Morse

ABSTRACT

BACKGROUND: Novel technologies to redirect T-cell killing against cancer cells are emerging. We hypothesised that metastatic human colorectal cancer (CRC) previously treated with conventional chemotherapy would be sensitive to T-cell killing mediated by carcinoembryonic antigen (CEA)/CD3-bispecific T-cell-engaging BiTE antibody (MEDI-565). METHODS: We analysed proliferation and lysis of CEA-positive (CEA+) CRC specimens that had survived previous systemic chemotherapy and biologic therapy to determine whether they could be killed by patient T cells engaged by MEDI-565 in vitro. RESULTS: At low concentrations (0.1-1 ng ml(-1)), MEDI-565+ T cells caused reduced proliferation and enhanced apoptosis of CEA+ human CRC specimens. High levels of soluble CEA did not impair killing by redirected T cells and there was no increase in resistance to T-cell killing despite multiple rounds of exposure. CONCLUSIONS: This study shows for the first time that metastatic CRC specimens derived from patients previously treated with conventional chemotherapy can be lysed by patient T cells. Clinical testing of cancer immunotherapies, such as MEDI-565 that result in exposure of tumours to large numbers of T cells, is warranted. More... »

PAGES

124

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6605364

DOI

http://dx.doi.org/10.1038/sj.bjc.6605364

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1022579921

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19953093


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Bispecific", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CD3 Complex", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoembryonic Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytotoxicity, Immunologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fas Ligand Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Granzymes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Activation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred NOD", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organoplatinum Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oxaliplatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "T-Lymphocytes, Cytotoxic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "fas Receptor", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Department of Surgery, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Program in Molecular Therapeutics, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Osada", 
        "givenName": "T", 
        "id": "sg:person.01114717615.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114717615.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Department of Medicine, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Duke Institute for Genome Sciences & Policy, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hsu", 
        "givenName": "D", 
        "id": "sg:person.0652031333.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652031333.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AstraZeneca (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418152.b", 
          "name": [
            "MedImmune, LLC, One MedImmune Way, Gaithersburg, MD 20878, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hammond", 
        "givenName": "S", 
        "id": "sg:person.0726645175.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726645175.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Department of Surgery, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Program in Molecular Therapeutics, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hobeika", 
        "givenName": "A", 
        "id": "sg:person.07741424047.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07741424047.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Department of Surgery, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Program in Molecular Therapeutics, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Devi", 
        "givenName": "G", 
        "id": "sg:person.01023745630.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023745630.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Department of Surgery, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Program in Molecular Therapeutics, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Clay", 
        "givenName": "T M", 
        "id": "sg:person.0706420433.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706420433.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Department of Surgery, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Program in Molecular Therapeutics, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Department of Pathology, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Department of Immunology, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lyerly", 
        "givenName": "H K", 
        "id": "sg:person.012507420117.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012507420117.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Program in Molecular Therapeutics, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA", 
            "Department of Medicine, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morse", 
        "givenName": "M A", 
        "id": "sg:person.013700705377.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013700705377.06"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.molimm.2005.07.034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000050936"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.molimm.2005.07.034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000050936"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00262-007-0298-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000839796", 
          "https://doi.org/10.1007/s00262-007-0298-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00262-007-0298-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000839796", 
          "https://doi.org/10.1007/s00262-007-0298-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/intimm/8.1.57", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004403567"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.20908", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011506028"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002371-200307000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014162674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002371-200307000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014162674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002371-200307000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014162674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/scbi.1998.0119", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024485267"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri1983", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026188939", 
          "https://doi.org/10.1038/nri1983"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri1983", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026188939", 
          "https://doi.org/10.1038/nri1983"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-008-0185-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026190668", 
          "https://doi.org/10.1007/s10549-008-0185-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-008-0185-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026190668", 
          "https://doi.org/10.1007/s10549-008-0185-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1146/annurev.immunol.25.022106.141527", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029126035"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-06-2760", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029642086"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00262-005-0001-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029966967", 
          "https://doi.org/10.1007/s00262-005-0001-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00262-005-0001-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029966967", 
          "https://doi.org/10.1007/s00262-005-0001-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00262-003-0496-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034809523", 
          "https://doi.org/10.1007/s00262-003-0496-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1359-6446(05)03554-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035538151"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1359-6446(05)03554-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035538151"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910570113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042755426"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cji.0b013e318156750c", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048770926"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cji.0b013e318156750c", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048770926"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.170.8.4397", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049032729"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdi320", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049789238"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1081/cnv-58878", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051008276"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1081/cnv-58878", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051008276"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.molimm.2005.03.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051763905"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cji.0b013e31819b7c70", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052604096"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cji.0b013e31819b7c70", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052604096"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cji.0b013e31819b7c70", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052604096"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m413303200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052813211"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1158545", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062457773"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.09.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203833"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074641647", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075286407", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-01", 
    "datePublishedReg": "2010-01-01", 
    "description": "BACKGROUND: Novel technologies to redirect T-cell killing against cancer cells are emerging. We hypothesised that metastatic human colorectal cancer (CRC) previously treated with conventional chemotherapy would be sensitive to T-cell killing mediated by carcinoembryonic antigen (CEA)/CD3-bispecific T-cell-engaging BiTE antibody (MEDI-565).\nMETHODS: We analysed proliferation and lysis of CEA-positive (CEA+) CRC specimens that had survived previous systemic chemotherapy and biologic therapy to determine whether they could be killed by patient T cells engaged by MEDI-565 in vitro.\nRESULTS: At low concentrations (0.1-1 ng ml(-1)), MEDI-565+ T cells caused reduced proliferation and enhanced apoptosis of CEA+ human CRC specimens. High levels of soluble CEA did not impair killing by redirected T cells and there was no increase in resistance to T-cell killing despite multiple rounds of exposure.\nCONCLUSIONS: This study shows for the first time that metastatic CRC specimens derived from patients previously treated with conventional chemotherapy can be lysed by patient T cells. Clinical testing of cancer immunotherapies, such as MEDI-565 that result in exposure of tumours to large numbers of T cells, is warranted.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.bjc.6605364", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2416449", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2435718", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "102"
      }
    ], 
    "name": "Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody", 
    "pagination": "124", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6b932aaac98883b22bac9b76d20ad8866df0f328d6dd19ecb269875bb3fe0e1a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19953093"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6605364"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1022579921"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6605364", 
      "https://app.dimensions.ai/details/publication/pub.1022579921"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:38", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000346_0000000346/records_99833_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/6605364"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605364'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605364'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605364'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605364'


 

This table displays all metadata directly associated to this object as RDF triples.

298 TRIPLES      21 PREDICATES      75 URIs      42 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6605364 schema:about N0ac4454cdc7f4f3596bee7a923ab6976
2 N1298720da08443928909a0296f3f99ee
3 N1def00e9feac4586b49bf090d0bbe6f5
4 N226cb0c171dd426983d056b52219761e
5 N2418695306964891a6fed369bba0e1f8
6 N241b402c83b6458c96cbe3ee34456d61
7 N27351f3ea26542ff9b223aa86e2a474b
8 N299372880caa4342bf2e311ea36b973e
9 N31bf13d54d6a43cb9d2c32aea1555a94
10 N3706f28fb14a48819631e2eb1ccdfa20
11 N38751f512fcd4aefbfb32450ff48fd39
12 N3b35cc4d88ec425a96cfaf12f0e56c6c
13 N4f1ced72968a4c66855273ea36525b52
14 N5201cdf3369c4dc78cf4e6b0cdc23094
15 N5f5572b688ce4d1ba3ef6ac1dc736d50
16 N67594facd1c4451891bb5fe3f806d6e7
17 Nba1e6a42f5094cf69a787f56ee2f98ac
18 Nc09f5e0011da4a128cf8ca05efe4933a
19 Ncac24e3d3e204c7ca567e94d5cf044e5
20 Ne5cc92f33cec42a39246025788987c11
21 Nf12226658e9a4eb8a4eaa4c00a9fc509
22 anzsrc-for:11
23 anzsrc-for:1112
24 schema:author Ncd86e74c886b4c3e94424de0b32ffbe2
25 schema:citation sg:pub.10.1007/s00262-003-0496-2
26 sg:pub.10.1007/s00262-005-0001-1
27 sg:pub.10.1007/s00262-007-0298-z
28 sg:pub.10.1007/s10549-008-0185-0
29 sg:pub.10.1038/nri1983
30 https://app.dimensions.ai/details/publication/pub.1074641647
31 https://app.dimensions.ai/details/publication/pub.1075286407
32 https://doi.org/10.1002/ijc.20908
33 https://doi.org/10.1002/ijc.2910570113
34 https://doi.org/10.1006/scbi.1998.0119
35 https://doi.org/10.1016/j.molimm.2005.03.007
36 https://doi.org/10.1016/j.molimm.2005.07.034
37 https://doi.org/10.1016/s1359-6446(05)03554-3
38 https://doi.org/10.1074/jbc.m413303200
39 https://doi.org/10.1081/cnv-58878
40 https://doi.org/10.1093/annonc/mdi320
41 https://doi.org/10.1093/intimm/8.1.57
42 https://doi.org/10.1097/00002371-200307000-00005
43 https://doi.org/10.1097/cji.0b013e318156750c
44 https://doi.org/10.1097/cji.0b013e31819b7c70
45 https://doi.org/10.1126/science.1158545
46 https://doi.org/10.1146/annurev.immunol.25.022106.141527
47 https://doi.org/10.1158/0008-5472.can-06-2760
48 https://doi.org/10.1200/jco.2003.09.027
49 https://doi.org/10.4049/jimmunol.170.8.4397
50 schema:datePublished 2010-01
51 schema:datePublishedReg 2010-01-01
52 schema:description BACKGROUND: Novel technologies to redirect T-cell killing against cancer cells are emerging. We hypothesised that metastatic human colorectal cancer (CRC) previously treated with conventional chemotherapy would be sensitive to T-cell killing mediated by carcinoembryonic antigen (CEA)/CD3-bispecific T-cell-engaging BiTE antibody (MEDI-565). METHODS: We analysed proliferation and lysis of CEA-positive (CEA+) CRC specimens that had survived previous systemic chemotherapy and biologic therapy to determine whether they could be killed by patient T cells engaged by MEDI-565 in vitro. RESULTS: At low concentrations (0.1-1 ng ml(-1)), MEDI-565+ T cells caused reduced proliferation and enhanced apoptosis of CEA+ human CRC specimens. High levels of soluble CEA did not impair killing by redirected T cells and there was no increase in resistance to T-cell killing despite multiple rounds of exposure. CONCLUSIONS: This study shows for the first time that metastatic CRC specimens derived from patients previously treated with conventional chemotherapy can be lysed by patient T cells. Clinical testing of cancer immunotherapies, such as MEDI-565 that result in exposure of tumours to large numbers of T cells, is warranted.
53 schema:genre research_article
54 schema:inLanguage en
55 schema:isAccessibleForFree true
56 schema:isPartOf N00ba535f51b84534a9845df816ca61cd
57 Ndbe796c0bef9427b93ff1f30e1af91d4
58 sg:journal.1017082
59 schema:name Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody
60 schema:pagination 124
61 schema:productId N38b15e4f8a96491e9fc3c75d6bdd7e44
62 N3c3b34d52cf74047a5a59f04d6c5aad0
63 N90309e64ea3b4e8994f3f038746a2c91
64 Nce6ffe49746e4692805941b96671ceac
65 Ndf1b62aac4cd4314857f85d1af2a43ee
66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022579921
67 https://doi.org/10.1038/sj.bjc.6605364
68 schema:sdDatePublished 2019-04-11T09:38
69 schema:sdLicense https://scigraph.springernature.com/explorer/license/
70 schema:sdPublisher N63530a2141114785a2045be220af0a4f
71 schema:url https://www.nature.com/articles/6605364
72 sgo:license sg:explorer/license/
73 sgo:sdDataset articles
74 rdf:type schema:ScholarlyArticle
75 N00ba535f51b84534a9845df816ca61cd schema:issueNumber 1
76 rdf:type schema:PublicationIssue
77 N025a3a2006cc41b99dd506ba7277b55f rdf:first sg:person.013700705377.06
78 rdf:rest rdf:nil
79 N0ac4454cdc7f4f3596bee7a923ab6976 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name CD3 Complex
81 rdf:type schema:DefinedTerm
82 N1298720da08443928909a0296f3f99ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Mice
84 rdf:type schema:DefinedTerm
85 N1def00e9feac4586b49bf090d0bbe6f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Carcinoembryonic Antigen
87 rdf:type schema:DefinedTerm
88 N226cb0c171dd426983d056b52219761e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Animals
90 rdf:type schema:DefinedTerm
91 N2418695306964891a6fed369bba0e1f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Antineoplastic Combined Chemotherapy Protocols
93 rdf:type schema:DefinedTerm
94 N241b402c83b6458c96cbe3ee34456d61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Antibodies, Bispecific
96 rdf:type schema:DefinedTerm
97 N27351f3ea26542ff9b223aa86e2a474b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name fas Receptor
99 rdf:type schema:DefinedTerm
100 N299372880caa4342bf2e311ea36b973e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Liver Neoplasms
102 rdf:type schema:DefinedTerm
103 N31bf13d54d6a43cb9d2c32aea1555a94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Drug Resistance, Neoplasm
105 rdf:type schema:DefinedTerm
106 N3706f28fb14a48819631e2eb1ccdfa20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Cytotoxicity, Immunologic
108 rdf:type schema:DefinedTerm
109 N38751f512fcd4aefbfb32450ff48fd39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Oxaliplatin
111 rdf:type schema:DefinedTerm
112 N38b15e4f8a96491e9fc3c75d6bdd7e44 schema:name doi
113 schema:value 10.1038/sj.bjc.6605364
114 rdf:type schema:PropertyValue
115 N3b35cc4d88ec425a96cfaf12f0e56c6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Organoplatinum Compounds
117 rdf:type schema:DefinedTerm
118 N3c3b34d52cf74047a5a59f04d6c5aad0 schema:name pubmed_id
119 schema:value 19953093
120 rdf:type schema:PropertyValue
121 N4f1ced72968a4c66855273ea36525b52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Mice, Inbred NOD
123 rdf:type schema:DefinedTerm
124 N5201cdf3369c4dc78cf4e6b0cdc23094 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Apoptosis
126 rdf:type schema:DefinedTerm
127 N5f5572b688ce4d1ba3ef6ac1dc736d50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Granzymes
129 rdf:type schema:DefinedTerm
130 N63530a2141114785a2045be220af0a4f schema:name Springer Nature - SN SciGraph project
131 rdf:type schema:Organization
132 N655241931f4a4878be7ced994239b0d3 rdf:first sg:person.0652031333.36
133 rdf:rest N7dfd23c7482443f1a28386f251bccf96
134 N67594facd1c4451891bb5fe3f806d6e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name T-Lymphocytes, Cytotoxic
136 rdf:type schema:DefinedTerm
137 N7dfd23c7482443f1a28386f251bccf96 rdf:first sg:person.0726645175.21
138 rdf:rest N8596a415f2f149c6a3bfe5762a15a981
139 N8596a415f2f149c6a3bfe5762a15a981 rdf:first sg:person.07741424047.51
140 rdf:rest Nccb2c9bb4bfd4b4c97a96cbb13c5f32e
141 N90309e64ea3b4e8994f3f038746a2c91 schema:name dimensions_id
142 schema:value pub.1022579921
143 rdf:type schema:PropertyValue
144 Nb236817144814b3597c62b2fd20266f2 rdf:first sg:person.012507420117.48
145 rdf:rest N025a3a2006cc41b99dd506ba7277b55f
146 Nba1e6a42f5094cf69a787f56ee2f98ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Colorectal Neoplasms
148 rdf:type schema:DefinedTerm
149 Nc09f5e0011da4a128cf8ca05efe4933a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Lymphocyte Activation
151 rdf:type schema:DefinedTerm
152 Ncac24e3d3e204c7ca567e94d5cf044e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Fas Ligand Protein
154 rdf:type schema:DefinedTerm
155 Nccb2c9bb4bfd4b4c97a96cbb13c5f32e rdf:first sg:person.01023745630.53
156 rdf:rest Nf758e9402f854b77a399a4e7b881e7d5
157 Ncd86e74c886b4c3e94424de0b32ffbe2 rdf:first sg:person.01114717615.49
158 rdf:rest N655241931f4a4878be7ced994239b0d3
159 Nce6ffe49746e4692805941b96671ceac schema:name nlm_unique_id
160 schema:value 0370635
161 rdf:type schema:PropertyValue
162 Ndbe796c0bef9427b93ff1f30e1af91d4 schema:volumeNumber 102
163 rdf:type schema:PublicationVolume
164 Ndf1b62aac4cd4314857f85d1af2a43ee schema:name readcube_id
165 schema:value 6b932aaac98883b22bac9b76d20ad8866df0f328d6dd19ecb269875bb3fe0e1a
166 rdf:type schema:PropertyValue
167 Ne5cc92f33cec42a39246025788987c11 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Adenocarcinoma
169 rdf:type schema:DefinedTerm
170 Nf12226658e9a4eb8a4eaa4c00a9fc509 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Humans
172 rdf:type schema:DefinedTerm
173 Nf758e9402f854b77a399a4e7b881e7d5 rdf:first sg:person.0706420433.90
174 rdf:rest Nb236817144814b3597c62b2fd20266f2
175 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
176 schema:name Medical and Health Sciences
177 rdf:type schema:DefinedTerm
178 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
179 schema:name Oncology and Carcinogenesis
180 rdf:type schema:DefinedTerm
181 sg:grant.2416449 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.bjc.6605364
182 rdf:type schema:MonetaryGrant
183 sg:grant.2435718 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.bjc.6605364
184 rdf:type schema:MonetaryGrant
185 sg:journal.1017082 schema:issn 0007-0920
186 1532-1827
187 schema:name British Journal of Cancer
188 rdf:type schema:Periodical
189 sg:person.01023745630.53 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
190 schema:familyName Devi
191 schema:givenName G
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023745630.53
193 rdf:type schema:Person
194 sg:person.01114717615.49 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
195 schema:familyName Osada
196 schema:givenName T
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114717615.49
198 rdf:type schema:Person
199 sg:person.012507420117.48 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
200 schema:familyName Lyerly
201 schema:givenName H K
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012507420117.48
203 rdf:type schema:Person
204 sg:person.013700705377.06 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
205 schema:familyName Morse
206 schema:givenName M A
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013700705377.06
208 rdf:type schema:Person
209 sg:person.0652031333.36 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
210 schema:familyName Hsu
211 schema:givenName D
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652031333.36
213 rdf:type schema:Person
214 sg:person.0706420433.90 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
215 schema:familyName Clay
216 schema:givenName T M
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706420433.90
218 rdf:type schema:Person
219 sg:person.0726645175.21 schema:affiliation https://www.grid.ac/institutes/grid.418152.b
220 schema:familyName Hammond
221 schema:givenName S
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726645175.21
223 rdf:type schema:Person
224 sg:person.07741424047.51 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
225 schema:familyName Hobeika
226 schema:givenName A
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07741424047.51
228 rdf:type schema:Person
229 sg:pub.10.1007/s00262-003-0496-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034809523
230 https://doi.org/10.1007/s00262-003-0496-2
231 rdf:type schema:CreativeWork
232 sg:pub.10.1007/s00262-005-0001-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029966967
233 https://doi.org/10.1007/s00262-005-0001-1
234 rdf:type schema:CreativeWork
235 sg:pub.10.1007/s00262-007-0298-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1000839796
236 https://doi.org/10.1007/s00262-007-0298-z
237 rdf:type schema:CreativeWork
238 sg:pub.10.1007/s10549-008-0185-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026190668
239 https://doi.org/10.1007/s10549-008-0185-0
240 rdf:type schema:CreativeWork
241 sg:pub.10.1038/nri1983 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026188939
242 https://doi.org/10.1038/nri1983
243 rdf:type schema:CreativeWork
244 https://app.dimensions.ai/details/publication/pub.1074641647 schema:CreativeWork
245 https://app.dimensions.ai/details/publication/pub.1075286407 schema:CreativeWork
246 https://doi.org/10.1002/ijc.20908 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011506028
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1002/ijc.2910570113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042755426
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1006/scbi.1998.0119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024485267
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1016/j.molimm.2005.03.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051763905
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1016/j.molimm.2005.07.034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000050936
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1016/s1359-6446(05)03554-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035538151
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1074/jbc.m413303200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052813211
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1081/cnv-58878 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051008276
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1093/annonc/mdi320 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049789238
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1093/intimm/8.1.57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004403567
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1097/00002371-200307000-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014162674
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1097/cji.0b013e318156750c schema:sameAs https://app.dimensions.ai/details/publication/pub.1048770926
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1097/cji.0b013e31819b7c70 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052604096
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1126/science.1158545 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062457773
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1146/annurev.immunol.25.022106.141527 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029126035
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1158/0008-5472.can-06-2760 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029642086
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1200/jco.2003.09.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203833
279 rdf:type schema:CreativeWork
280 https://doi.org/10.4049/jimmunol.170.8.4397 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049032729
281 rdf:type schema:CreativeWork
282 https://www.grid.ac/institutes/grid.189509.c schema:alternateName Duke University Hospital
283 schema:name Department of Immunology, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
284 Department of Medicine, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
285 Department of Pathology, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
286 Department of Surgery, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
287 Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
288 Duke Institute for Genome Sciences & Policy, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
289 Program in Molecular Therapeutics, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
290 rdf:type schema:Organization
291 https://www.grid.ac/institutes/grid.26009.3d schema:alternateName Duke University
292 schema:name Department of Surgery, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
293 Duke Comprehensive Cancer Center, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
294 Program in Molecular Therapeutics, Duke University Medical Center, 401 MSRB, Research Drive, Durham, NC 27710, USA
295 rdf:type schema:Organization
296 https://www.grid.ac/institutes/grid.418152.b schema:alternateName AstraZeneca (United States)
297 schema:name MedImmune, LLC, One MedImmune Way, Gaithersburg, MD 20878, USA
298 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...